S&P 500   5,078.18
DOW   38,972.41
QQQ   437.60
bluebird bio stock is ripe for a 400% institutional short squeeze
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
3 lithium stocks to ride a multi-year cycle
Goldman upgraded Nvidia stock, one metric says it could go higher
Critical asset just had biggest fall on record (Ad)
Salesforce stock got a boost. Is it growing off the Nvidia boom?
Autozone stock price is still in the rally zone
Critical asset just had biggest fall on record (Ad)
Closing prices for crude oil, gold and other commodities
New highs are coming for Lowe’s stock despite mixed results
S&P 500   5,078.18
DOW   38,972.41
QQQ   437.60
bluebird bio stock is ripe for a 400% institutional short squeeze
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
3 lithium stocks to ride a multi-year cycle
Goldman upgraded Nvidia stock, one metric says it could go higher
Critical asset just had biggest fall on record (Ad)
Salesforce stock got a boost. Is it growing off the Nvidia boom?
Autozone stock price is still in the rally zone
Critical asset just had biggest fall on record (Ad)
Closing prices for crude oil, gold and other commodities
New highs are coming for Lowe’s stock despite mixed results
S&P 500   5,078.18
DOW   38,972.41
QQQ   437.60
bluebird bio stock is ripe for a 400% institutional short squeeze
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
3 lithium stocks to ride a multi-year cycle
Goldman upgraded Nvidia stock, one metric says it could go higher
Critical asset just had biggest fall on record (Ad)
Salesforce stock got a boost. Is it growing off the Nvidia boom?
Autozone stock price is still in the rally zone
Critical asset just had biggest fall on record (Ad)
Closing prices for crude oil, gold and other commodities
New highs are coming for Lowe’s stock despite mixed results
S&P 500   5,078.18
DOW   38,972.41
QQQ   437.60
bluebird bio stock is ripe for a 400% institutional short squeeze
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
3 lithium stocks to ride a multi-year cycle
Goldman upgraded Nvidia stock, one metric says it could go higher
Critical asset just had biggest fall on record (Ad)
Salesforce stock got a boost. Is it growing off the Nvidia boom?
Autozone stock price is still in the rally zone
Critical asset just had biggest fall on record (Ad)
Closing prices for crude oil, gold and other commodities
New highs are coming for Lowe’s stock despite mixed results
OTCMKTS:BIOTU

Biotech Acquisition (BIOTU) Stock Price, News & Analysis

$10.14
-0.84 (-7.65%)
(As of 02/2/2023)
Today's Range
$10.14
$10.17
50-Day Range
$10.14
$10.14
52-Week Range
$8.73
$11.11
Volume
1,300 shs
Average Volume
4,444 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

BIOTU stock logo

About Biotech Acquisition Stock (OTCMKTS:BIOTU)

Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.

BIOTU Stock Price History

BIOTU Stock News Headlines

Biotech Acquisition (OTCMKTS:BIOTU) Shares Down 7.7%
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
CERo Therapeutics Holdings Inc (CERO)
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
4 Biotech Stock Moves I Made Amid a Bullish Call on the Sector
What Has Insiders Eyeing This Biotech Stock
7 ‘Strong Buy’ Biotech Stocks to Rejuvenate Your Portfolio
See More Headlines
Receive BIOTU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biotech Acquisition and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Shell Companies
Sub-Industry
N/A
Current Symbol
OTCMKTS:BIOTU
Web
N/A
Phone
N/A
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Dr. Michael Shleifer Ph.D. (Age 49)
    Chairman & CEO
  • Mr. Thomas Fratacci (Age 45)
    CFO & Treasurer
  • Mr. Ivan Jarry (Age 45)
    Chief Operating Officer
  • Mr. Albert F. Hummel M.B.A. (Age 77)
    Chief Investment Officer & Director














BIOTU Stock Analysis - Frequently Asked Questions

How have BIOTU shares performed in 2024?

Biotech Acquisition's stock was trading at $10.14 at the beginning of the year. Since then, BIOTU shares have increased by 0.0% and is now trading at $10.14.
View the best growth stocks for 2024 here
.

How do I buy shares of Biotech Acquisition?

Shares of BIOTU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:BIOTU) was last updated on 2/28/2024 by MarketBeat.com Staff